Literature DB >> 23881237

[Participation and support of clinical studies and other scientific investigations. Statement of the German Society for Pathology].

C Röcken1, H Höfler, M Hummel, R Meyermann, C Zietz, P Schirmacher.   

Abstract

Clinical studies and preclinical investigations are essential in order to test new therapies and diagnostics with the aim of sustained improvement in the treatment of patients. Fortunately, the number of clinical studies is continuously increasing and pathology and tissue-based research are included more often. The German Society for Pathology (DGP) and the pathologists it represents want to and can support this process and our clinical partners as best as possible as an equal partner. With our technologies and our specific expertise we can make a substantial contribution to the quality and the success of preclinical investigations, clinical studies and implementation of the results into clinical pathological diagnostics. In order to support this process the DGP has formulated a statement on the participation and support of clinical studies and other scientific investigations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23881237     DOI: 10.1007/s00292-013-1793-y

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  2 in total

1.  [Recovery of paraffin blocks and central archiving : Experiences of the Kiel lymph node registry and the German study group for Hodgkin lymphoma].

Authors:  M Čavčić; I Oschlies; M Fuchs; A Engert; W Klapper
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

2.  [Specialized histopathological second opinion of advanced ovarian cancer. Experiences with collectives from prospective randomized phase III studies].

Authors:  S Kommoss; J Pfisterer; A du Bois; D Schmidt; F Kommoss
Journal:  Pathologe       Date:  2014-07       Impact factor: 1.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.